Get started Log in

VIVE — Vivesto AB Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Market Cap
SEK79.82m
Enterprise Value
SEK56.31m
Revenue

Brief: Vivesto Q2 Oper Loss Narrows To SEK 28.8 Mln
24/08/2023 07:24
Brief: Vivesto Q2 EPS at SEK -0.05
24/08/2023 07:15
Brief: Vivesto Announces Early Termination Of Patient Enrollment
04/08/2023 09:05
Brief: Vivesto Announces Positive Paccal Vet FDA Pre-Submission Meeting
16/06/2023 07:09
Brief: Vivesto Q1 Net Loss After Tax Narrows To SEK 20.4 Mln
25/05/2023 07:17
Brief: Vivesto Q1 Operating Profit at SEK -21.537 Million
25/05/2023 07:03
Brief: Vivesto, Elevar Seek to Transfer Apealea Rights
24/03/2023 17:45
Brief: Vivesto Initiates Clinical Development Of Paccal Vet In Veterinary Oncology
20/03/2023 06:14
Brief: Vivesto Q4 Oper Loss Widens To SEK 31.0 Mln
23/02/2023 07:27
Brief: Vivesto Q4 EPS at SEK -0.06
23/02/2023 06:37
Brief: Vivesto: Inceptua Decides To Withdraw Market Authorization Application For Apealea In Switzerland
11/01/2023 07:04
Brief: Vivesto Announces Erik Kinnman As New CEO From January
28/12/2022 07:32
Brief: Vivesto's Acting CEO Stays In Position During Transition Period
30/11/2022 09:50
Brief: Vivesto Appoints Erik Kinnman As CEO
21/11/2022 07:34
Brief: Vivesto Q3 Oper Result Turns To Profit Of SEK 71.3 Mln
17/11/2022 07:24
Brief: Vivesto Acting CEO Christer Nordstedt Resigns
04/11/2022 06:41
Brief: Vivesto Q2 Operating Loss Narrows To SEK 36.3 Mln
25/08/2022 07:14
Brief: Vivesto Appoints Christer Nordstedt As Acting CEO
21/07/2022 14:33
Brief: Vivesto Winds Down Its Activities In Russia
05/07/2022 07:46
Brief: Vivesto Appoints Robert Maiorana As Acting CFO
01/07/2022 06:44